Answer
Ruxolitinib selectively inhibits the Janus kinase enzymes JAK1 and JAK2.
Sources for this answer
- Opzelura 15 mg/g creamIncyte Biosciences UK Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 4Document updated
Sources checked
loading page…
Sources checked
Explore the tools and reference material available on iatroX.
Explore askiatroX